Repare Therapeutics Inc. Quarterly Nonoperating Income (Expense) in USD from Q2 2019 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Repare Therapeutics Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2019 to Q4 2024.
  • Repare Therapeutics Inc. Nonoperating Income (Expense) for the quarter ending December 31, 2024 was $1.98M, a 34.7% decline year-over-year.
  • Repare Therapeutics Inc. Nonoperating Income (Expense) for the twelve months ending December 31, 2024 was $10.3M, a 21.2% decline year-over-year.
  • Repare Therapeutics Inc. annual Nonoperating Income (Expense) for 2024 was $10.3M, a 21.2% decline from 2023.
  • Repare Therapeutics Inc. annual Nonoperating Income (Expense) for 2023 was $13M, a 121% increase from 2022.
  • Repare Therapeutics Inc. annual Nonoperating Income (Expense) for 2022 was $5.9M, a 7868% increase from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $10.3M $1.98M -$1.05M -34.7% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-03
Q3 2024 $11.3M $2.45M -$789K -24.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $12.1M $2.87M -$551K -16.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $12.7M $2.98M -$381K -11.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $13M $3.03M +$25K +0.83% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-03
Q3 2023 $13M $3.24M +$1.12M +53.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $11.9M $3.42M +$2.75M +408% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $9.15M $3.36M +$3.25M +3127% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $5.9M $3M +$2.97M +9281% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $2.93M $2.12M +$2.04M +2578% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $889K $674K +$737K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $152K $104K +$78K +300% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $74K $32K -$228K -87.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-28
Q3 2021 $302K $79K -$363K -82.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $665K -$63K -$654K -111% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $1.32M $26K +$1.76M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$440K $260K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-01
Q3 2020 $442K +$1.23M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $591K +$1.05M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$1.73M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q3 2019 -$791K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$454K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.